These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 34839358)

  • 1. ONECUT2 facilitates hepatocellular carcinoma metastasis by transcriptionally upregulating FGF2 and ACLY.
    Liu D; Zhang T; Chen X; Zhang B; Wang Y; Xie M; Ji X; Sun M; Huang W; Xia L
    Cell Death Dis; 2021 Nov; 12(12):1113. PubMed ID: 34839358
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SIX4 promotes hepatocellular carcinoma metastasis through upregulating YAP1 and c-MET.
    He Q; Lin Z; Wang Z; Huang W; Tian D; Liu M; Xia L
    Oncogene; 2020 Dec; 39(50):7279-7295. PubMed ID: 33046796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ATP citrate lyase inhibitor triggers endoplasmic reticulum stress to induce hepatocellular carcinoma cell apoptosis via p-eIF2α/ATF4/CHOP axis.
    Zheng Y; Zhou Q; Zhao C; Li J; Yu Z; Zhu Q
    J Cell Mol Med; 2021 Feb; 25(3):1468-1479. PubMed ID: 33393219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ATP citrate lyase promotes the progression of hepatocellular carcinoma by activating the REGγ-proteasome pathway.
    Cai Q; Zhu H; Dai Y; Zhou Q; Zhang Q; Zhu Q
    Mol Carcinog; 2024 Oct; 63(10):1874-1891. PubMed ID: 38888205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IGF1-mediated HOXA13 overexpression promotes colorectal cancer metastasis through upregulating ACLY and IGF1R.
    Qiao C; Huang W; Chen J; Feng W; Zhang T; Wang Y; Liu D; Ji X; Xie M; Sun M; Fan D; Wu K; Xia L
    Cell Death Dis; 2021 Jun; 12(6):564. PubMed ID: 34075028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ATP-citrate lyase regulates stemness and metastasis in hepatocellular carcinoma via the Wnt/β-catenin signaling pathway.
    Han Q; Chen CA; Yang W; Liang D; Lv HW; Lv GS; Zong QN; Wang HY
    Hepatobiliary Pancreat Dis Int; 2021 Jun; 20(3):251-261. PubMed ID: 33129711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Homeobox B5 promotes metastasis and poor prognosis in Hepatocellular Carcinoma, via FGFR4 and CXCL1 upregulation.
    He Q; Huang W; Liu D; Zhang T; Wang Y; Ji X; Xie M; Sun M; Tian D; Liu M; Xia L
    Theranostics; 2021; 11(12):5759-5777. PubMed ID: 33897880
    [No Abstract]   [Full Text] [Related]  

  • 8. Interleukin 1β-mediated HOXC10 Overexpression Promotes Hepatocellular Carcinoma Metastasis by Upregulating PDPK1 and VASP.
    Dang Y; Chen J; Feng W; Qiao C; Han W; Nie Y; Wu K; Fan D; Xia L
    Theranostics; 2020; 10(8):3833-3848. PubMed ID: 32206125
    [No Abstract]   [Full Text] [Related]  

  • 9. T-box transcription factor 19 promotes hepatocellular carcinoma metastasis through upregulating EGFR and RAC1.
    Ji X; Chen X; Zhang B; Xie M; Zhang T; Luo X; Liu D; Feng Y; Wang Y; Sun M; Li C; Huang W; Xia L
    Oncogene; 2022 Apr; 41(15):2225-2238. PubMed ID: 35217793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FOXC1 promotes HCC proliferation and metastasis by Upregulating DNMT3B to induce DNA Hypermethylation of CTH promoter.
    Lin Z; Huang W; He Q; Li D; Wang Z; Feng Y; Liu D; Zhang T; Wang Y; Xie M; Ji X; Sun M; Tian D; Xia L
    J Exp Clin Cancer Res; 2021 Feb; 40(1):50. PubMed ID: 33522955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HOXB7 promotes tumor progression via bFGF-induced activation of MAPK/ERK pathway and indicated poor prognosis in hepatocellular carcinoma.
    Wang WM; Xu Y; Wang YH; Sun HX; Sun YF; He YF; Zhu QF; Hu B; Zhang X; Xia JL; Qiu SJ; Zhou J; Yang XR; Fan J
    Oncotarget; 2017 Jul; 8(29):47121-47135. PubMed ID: 28454092
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined RNAi of CTTN and FGF2 Modulates Cell Migration, Invasion and G1/S Transition of Hepatocellular Carcinoma through Ras/ERK Signaling Pathway.
    Zhou J; Liu J; Li T; Zhong Q; Yu H
    Curr Cancer Drug Targets; 2024; 24(8):791-803. PubMed ID: 38031266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comprehensive profiling of novel microRNA-9 targets and a tumor suppressor role of microRNA-9 via targeting IGF2BP1 in hepatocellular carcinoma.
    Zhang J; Cheng J; Zeng Z; Wang Y; Li X; Xie Q; Jia J; Yan Y; Guo Z; Gao J; Yao M; Chen X; Lu F
    Oncotarget; 2015 Dec; 6(39):42040-52. PubMed ID: 26547929
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MiR-195 is a key negative regulator of hepatocellular carcinoma metastasis by targeting FGF2 and VEGFA.
    Wang M; Zhang J; Tong L; Ma X; Qiu X
    Int J Clin Exp Pathol; 2015; 8(11):14110-20. PubMed ID: 26823724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of ACLY by SEC63 deploys metabolic reprogramming to facilitate hepatocellular carcinoma metastasis upon endoplasmic reticulum stress.
    Hu C; Xin Z; Sun X; Hu Y; Zhang C; Yan R; Wang Y; Lu M; Huang J; Du X; Xing B; Liu X
    J Exp Clin Cancer Res; 2023 May; 42(1):108. PubMed ID: 37122003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. H2.0-like homeobox 1 acts as a tumor suppressor in hepatocellular carcinoma.
    Liu T; Chen J; Xiao S; Lei X
    Tumour Biol; 2016 May; 37(5):6419-28. PubMed ID: 26631039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PRRX1 deficiency induces mesenchymal-epithelial transition through PITX2/miR-200-dependent SLUG/CTNNB1 regulation in hepatocellular carcinoma.
    Chen W; Wu J; Shi W; Zhang G; Chen X; Ji A; Wang Z; Wu J; Jiang C
    Cancer Sci; 2021 Jun; 112(6):2158-2172. PubMed ID: 33587761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of forkhead box C1 promotes tumor metastasis and indicates poor prognosis in hepatocellular carcinoma.
    Xia L; Huang W; Tian D; Zhu H; Qi X; Chen Z; Zhang Y; Hu H; Fan D; Nie Y; Wu K
    Hepatology; 2013 Feb; 57(2):610-24. PubMed ID: 22911555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sox12, a direct target of FoxQ1, promotes hepatocellular carcinoma metastasis through up-regulating Twist1 and FGFBP1.
    Huang W; Chen Z; Shang X; Tian D; Wang D; Wu K; Fan D; Xia L
    Hepatology; 2015 Jun; 61(6):1920-33. PubMed ID: 25704764
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EB2 promotes hepatocellular carcinoma proliferation and metastasis via MAPK/ERK pathway by modulating microtubule dynamics.
    Zhong FJ; Li YM; Xu C; Sun B; Wang JL; Yang LY
    Clin Sci (Lond); 2021 Apr; 135(7):847-864. PubMed ID: 33755094
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.